{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:38:32Z","timestamp":1790037512720,"version":"4.0.1"},"reference-count":43,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2016,12,21]]},"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Estimate survival after acute myocardial infarction (AMI) in the general population aged 60 and over and the effect of recommended treatments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Cohort study in the UK with routinely collected data between January 1987 and March 2011.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>310 general practices that contributed to The Health Improvement Network (THIN) database.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>4 cohorts who reached the age of 60, 65, 70, or 75\u2005years between 1987 and 2011 included 16\u2005744, 43\u2005528, 73\u2005728, and 76\u2005392 participants, respectively. Participants with a history of AMI were matched on sex, year of birth, and general practice to 3 controls each.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcome measures<\/jats:title>\n                  <jats:p>The hazard of all-cause mortality associated with AMI was calculated by a multilevel Cox's proportional hazards regression, adjusted for sex, year of birth, socioeconomic status, angina, heart failure, other cardiovascular conditions, chronic kidney disease, diabetes, hypertension, hypercholesterolaemia, alcohol consumption, body mass index, smoking status, coronary revascularisation, prescription of \u03b2-blockers, ACE inhibitors, calcium-channel blockers, aspirin, or statins, and general practice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with no history of AMI by age 60, 65, 70, or 75, having had 1 AMI was associated with an adjusted hazard of mortality of 1.80 (95% CI 1.60 to 2.02), 1.71 (1.59 to 1.84), 1.50 (1.42 to 1.59), or 1.45 (1.38 to 1.53), respectively, and having had multiple AMIs with a hazard of 1.92 (1.60 to 2.29), 1.87 (1.68 to 2.07), 1.66 (1.53 to 1.80), or 1.63 (1.51 to 1.76), respectively. Survival was better after statins (HR range across the 4 cohorts 0.74\u20130.81), \u03b2-blockers (0.79\u20130.85), or coronary revascularisation (in first 5\u2005years) (0.72\u20130.80); unchanged after calcium-channel blockers (1.00\u20131.07); and worse after aspirin (1.05\u20131.10) or ACE inhibitors (1.10\u20131.25).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The hazard of death after AMI is less than reported by previous studies, and standard treatments of aspirin or ACE inhibitors prescription may be of little benefit or even cause harm.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-013570","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T21:11:22Z","timestamp":1485292282000},"page":"e013570","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987\u20132011"],"prefix":"10.1136","volume":"7","author":[{"given":"Lisanne A","family":"Gitsels","sequence":"first","affiliation":[{"name":"School of Computing Sciences, University of East Anglia, Norwich Research Park, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kulinskaya","sequence":"additional","affiliation":[{"name":"School of Computing Sciences, University of East Anglia, Norwich Research Park, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Steel","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,1,24]]},"reference":[{"key":"2025101811152668000_7.1.e013570.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b36"},{"key":"2025101811152668000_7.1.e013570.2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2318"},{"key":"2025101811152668000_7.1.e013570.3","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2009.098087"},{"key":"2025101811152668000_7.1.e013570.4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF03391642","article-title":"WHO MONICA project: what have we learned and where to go from here?","volume":"33","author":"Luepker","year":"2012","journal-title":"Public Health Rev"},{"key":"2025101811152668000_7.1.e013570.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.111.964700"},{"key":"2025101811152668000_7.1.e013570.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d8059"},{"key":"2025101811152668000_7.1.e013570.7","doi-asserted-by":"publisher","DOI":"10.1186\/1475-9276-13-19"},{"key":"2025101811152668000_7.1.e013570.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.05.016"},{"key":"2025101811152668000_7.1.e013570.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.882555"},{"key":"2025101811152668000_7.1.e013570.10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.20.2476"},{"key":"2025101811152668000_7.1.e013570.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6650"},{"key":"2025101811152668000_7.1.e013570.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.06.040"},{"key":"2025101811152668000_7.1.e013570.13","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-9-51"},{"key":"2025101811152668000_7.1.e013570.14","unstructured":"Townsend N , Williams J , Bhatnagar P , et al . Cardiovascular disease statistics, 2014. British Heart Foundation, 2014."},{"key":"2025101811152668000_7.1.e013570.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17018-9"},{"key":"2025101811152668000_7.1.e013570.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2350"},{"key":"2025101811152668000_7.1.e013570.17","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform Prim Care"},{"key":"2025101811152668000_7.1.e013570.18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/pds.1686","article-title":"Validation of death and suicide recording on the THIN UK primary care database","volume":"18","author":"Hall","year":"2009","journal-title":"Pharmacoepidem Drug Safe"},{"key":"2025101811152668000_7.1.e013570.19","first-page":"235","article-title":"Type and timing of heralding in ST-elevation and non-ST-elevation myocardial infarction: an analysis of prospectively collected electronic healthcare records linked to the national registry of acute coronary syndromes","volume":"2","author":"Herrett","year":"2013","journal-title":"Eur Heart J"},{"key":"2025101811152668000_7.1.e013570.20","unstructured":"Experian. Mosaic UK: the consumer classification of the UK. http:\/\/www.experian.co.uk\/assets\/business-strategies\/brochures\/Mosaic_UK_2009_brochure.pdf (16 October 2015)."},{"key":"2025101811152668000_7.1.e013570.21","unstructured":"Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press. http:\/\/www.medicinescomplete.com. (8 March 2016)."},{"key":"2025101811152668000_7.1.e013570.22","unstructured":"National Institute for Health and Care Excellence. NICE clinical guideline 172. Myocardial infarction: cardiac rehabilitation and prevention of further MI. 2013.nice.org.uk\/guidance\/cg172"},{"key":"2025101811152668000_7.1.e013570.23","unstructured":"National Institute for Health and Care Excellence. NICE clinical guideline 48. MI- secondary prevention: secondary prevention in primary and secondary care for patients following a myocardial infarction. 2013. nice.org.uk\/guidance\/cg48"},{"key":"2025101811152668000_7.1.e013570.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39609.449676.25"},{"key":"2025101811152668000_7.1.e013570.25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-329"},{"key":"2025101811152668000_7.1.e013570.26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/fampra\/cmr039","article-title":"The use of electronic databases in primary care research","volume":"28","author":"Shephard","year":"2011","journal-title":"BMC Family Practice"},{"key":"2025101811152668000_7.1.e013570.27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pds.1934","article-title":"Issues in multiple imputation of missing data for large general practice clinical databases","volume":"19","author":"Marston","year":"2010","journal-title":"Pharmacoepidem Drug Safe"},{"key":"2025101811152668000_7.1.e013570.28","unstructured":"Buuren S van . Flexible imputation of missing data. CRC press, 2012."},{"key":"2025101811152668000_7.1.e013570.29","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199305000-00006"},{"key":"2025101811152668000_7.1.e013570.30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1536867X0600600105","article-title":"Explained variation for survival models","volume":"6","author":"Royston","year":"2006","journal-title":"Stata J"},{"key":"2025101811152668000_7.1.e013570.31","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181c30fb2"},{"key":"2025101811152668000_7.1.e013570.32","unstructured":"Harrell FE Jr . Package \u2018rms\u2019 version 4.3-1. http:\/\/biostat.mc.vanderbilt.edu\/rms (16 October 2015)."},{"key":"2025101811152668000_7.1.e013570.33","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2368"},{"key":"2025101811152668000_7.1.e013570.34","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.20.2484"},{"issue":"P","key":"2025101811152668000_7.1.e013570.35","doi-asserted-by":"crossref","first-page":"P27","DOI":"10.4244\/EIJV8SPA6","article-title":"ACS and STEMI treatment: gender-related issues","volume":"8","author":"Chieffo","year":"2012","journal-title":"EuroIntervention"},{"key":"2025101811152668000_7.1.e013570.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01308-0"},{"key":"2025101811152668000_7.1.e013570.37","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"2025101811152668000_7.1.e013570.38","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1998.v136.89745"},{"key":"2025101811152668000_7.1.e013570.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512213332503"},{"key":"2025101811152668000_7.1.e013570.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271001"},{"key":"2025101811152668000_7.1.e013570.41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271003"},{"key":"2025101811152668000_7.1.e013570.42","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050032"},{"key":"2025101811152668000_7.1.e013570.43","first-page":"V59","article-title":"Aspirin in coronary heart disease. The Coronary Drug Project Research Group","volume":"62","year":"1980","journal-title":"Circulation"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-013570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:15:35Z","timestamp":1760811335000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-013570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,24]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1136\/bmjopen-2016-013570"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-013570","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}